RxDoctor Payments Data

Rebecca Priebe

Family · Middletown, RINPI 1992351811

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,246 of the $3,732 with a category attached, or 87.0%. It is spread thinly across 22 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,732in general payments, 2019–2025

Across 103 payments — averaging $36.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sun Pharmaceutical Industries Inc.$602
  • E.r. Squibb & Sons, L.L.C.$452
  • AbbVie$377
  • Regeneron Healthcare Solutions, Inc.$322
  • Arcutis Biotherapeutics, Inc.$295
  • Lilly USA, LLC$267
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,24687%
  • Education$48713%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,732 in reported general payments places this provider in the 90th percentile of 457 family providers in Rhode Island.

See all family providers in Rhode Island

Medicare billing

Part B allowed, 2024
$172,855
Medicare patients
473
Services billed
2,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OpzeluraRuxolitinib Phosphate22$45,025
Tacrolimus86$25,313
Fluorouracil97$7,321
Ketoconazole123$2,861
Clobetasol Propionate39$2,816
Fluocinolone Acetonide32$1,351
Calcipotriene15$1,239
Triamcinolone Acetonide82$1,021
Betamethasone Dipropionate17$1,014
Fluconazole28$663
Nystatin18$599
Ammonium Lactate21$465
Minoxidil11$92

Paid to pharmacies, not to this prescriber.

Other family in Middletown

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →